These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
65 related items for PubMed ID: 2468507
21. Binding of malaria T cell epitopes to DR and DQ molecules in vitro correlates with immunogenicity in vivo: identification of a universal T cell epitope in the Plasmodium falciparum circumsporozoite protein. Calvo-Calle JM, Hammer J, Sinigaglia F, Clavijo P, Moya-Castro ZR, Nardin EH. J Immunol; 1997 Aug 01; 159(3):1362-73. PubMed ID: 9233633 [Abstract] [Full Text] [Related]
22. Role of antigen-specific T cell help in the generation of in vivo antibody responses. II. Sustained antigen-specific T cell help is required to induce a specific antibody response. Finkelman FD, Villacreses N, Holmes JM. J Immunol; 1992 Dec 15; 149(12):3845-50. PubMed ID: 1281191 [Abstract] [Full Text] [Related]
23. Vaccination with a purified blood-stage malaria antigen in mice: correlation of protection with T cell mediated immunity. Playfair JH, De Souza JB, Freeman RR, Holder AA. Clin Exp Immunol; 1985 Oct 15; 62(1):19-23. PubMed ID: 2933196 [Abstract] [Full Text] [Related]
24. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Romero P, Maryanski JL, Corradin G, Nussenzweig RS, Nussenzweig V, Zavala F. Nature; 1989 Sep 28; 341(6240):323-6. PubMed ID: 2477703 [Abstract] [Full Text] [Related]
25. A multiple antigen peptide from the repetitive sequence of the Plasmodium malariae circumsporozoite protein induces a specific antibody response in mice of various H-2 haplotypes. Del Giudice G, Tougne C, Louis JA, Lambert PH, Bianchi E, Bonelli F, Chiappinelli L, Pessi A. Eur J Immunol; 1990 Jul 28; 20(7):1619-22. PubMed ID: 2201549 [Abstract] [Full Text] [Related]
26. A bicistronic DNA vaccine containing apical membrane antigen 1 and merozoite surface protein 4/5 can prime humoral and cellular immune responses and partially protect mice against virulent Plasmodium chabaudi adami DS malaria. Rainczuk A, Scorza T, Spithill TW, Smooker PM. Infect Immun; 2004 Oct 28; 72(10):5565-73. PubMed ID: 15385453 [Abstract] [Full Text] [Related]
27. Immunogenicity and in vitro protective efficacy of a polyepitope Plasmodium falciparum candidate vaccine constructed by epitope shuffling. Cai Q, Peng G, Bu L, Lin Y, Zhang L, Lustigmen S, Wang H. Vaccine; 2007 Jul 09; 25(28):5155-65. PubMed ID: 17548134 [Abstract] [Full Text] [Related]
34. Induction of specific T-cell responses, opsonizing antibodies, and protection against Plasmodium chabaudi adami infection in mice vaccinated with genomic expression libraries expressed in targeted and secretory DNA vectors. Rainczuk A, Scorza T, Smooker PM, Spithill TW. Infect Immun; 2003 Aug 09; 71(8):4506-15. PubMed ID: 12874330 [Abstract] [Full Text] [Related]
35. Synthetic Plasmodium falciparum circumsporozoite peptides elicit heterogenous L3T4+ T cell proliferative responses in H-2b mice. Togna AR, Del Giudice G, Verdini AS, Bonelli F, Pessi A, Engers HD, Corradin G. J Immunol; 1986 Nov 01; 137(9):2956-60. PubMed ID: 2428881 [Abstract] [Full Text] [Related]
36. Resolution of acute malarial infections by T cell-dependent non-antibody-mediated mechanisms of immunity. Cavacini LA, Parke LA, Weidanz WP. Infect Immun; 1990 Sep 01; 58(9):2946-50. PubMed ID: 2387628 [Abstract] [Full Text] [Related]